ITUB20160863A1 - Metodo per la diagnosi e la tipizzazione dell’amiloidosi - Google Patents

Metodo per la diagnosi e la tipizzazione dell’amiloidosi

Info

Publication number
ITUB20160863A1
ITUB20160863A1 ITUB2016A000863A ITUB20160863A ITUB20160863A1 IT UB20160863 A1 ITUB20160863 A1 IT UB20160863A1 IT UB2016A000863 A ITUB2016A000863 A IT UB2016A000863A IT UB20160863 A ITUB20160863 A IT UB20160863A IT UB20160863 A1 ITUB20160863 A1 IT UB20160863A1
Authority
IT
Italy
Prior art keywords
amyloidosis
typing
diagnosis
Prior art date
Application number
ITUB2016A000863A
Other languages
English (en)
Inventor
Chiara Castellani
Annalisa Angelini
Marialuisa Valente
Gaetano Thiene
Marny Fedrigo
Original Assignee
Univ Degli Studi Padova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Padova filed Critical Univ Degli Studi Padova
Priority to ITUB2016A000863A priority Critical patent/ITUB20160863A1/it
Priority to EP17710484.1A priority patent/EP3417295B1/en
Priority to PCT/EP2017/053662 priority patent/WO2017140872A1/en
Publication of ITUB20160863A1 publication Critical patent/ITUB20160863A1/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ITUB2016A000863A 2016-02-18 2016-02-18 Metodo per la diagnosi e la tipizzazione dell’amiloidosi ITUB20160863A1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITUB2016A000863A ITUB20160863A1 (it) 2016-02-18 2016-02-18 Metodo per la diagnosi e la tipizzazione dell’amiloidosi
EP17710484.1A EP3417295B1 (en) 2016-02-18 2017-02-17 Method for the diagnosis and typing of amyloidosis
PCT/EP2017/053662 WO2017140872A1 (en) 2016-02-18 2017-02-17 Method for the diagnosis and typing of amyloidosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUB2016A000863A ITUB20160863A1 (it) 2016-02-18 2016-02-18 Metodo per la diagnosi e la tipizzazione dell’amiloidosi

Publications (1)

Publication Number Publication Date
ITUB20160863A1 true ITUB20160863A1 (it) 2017-08-18

Family

ID=56116497

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUB2016A000863A ITUB20160863A1 (it) 2016-02-18 2016-02-18 Metodo per la diagnosi e la tipizzazione dell’amiloidosi

Country Status (3)

Country Link
EP (1) EP3417295B1 (it)
IT (1) ITUB20160863A1 (it)
WO (1) WO2017140872A1 (it)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023036447A1 (de) 2021-09-13 2023-03-16 Mycor Gmbh Verfahren und vorrichtung zur bestimmung von erregungspotentialen des menschlichen herzens

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
FALK RODNEY H: "Diagnosis and management of the cardiac amyloidoses", CIRCULATION, LIPPINCOT WILLIAMS AND WILKINS, BALTIMORE, US, vol. 112, no. 13, 27 September 2005 (2005-09-27), pages 2047 - 2060, XP002485173, ISSN: 1524-4539, DOI: 10.1161/CIRCULATIONAHA.104.489187 *
GIRISH C. MELKANI ET AL: "Huntington's Disease Induced Cardiac Amyloidosis Is Reversed by Modulating Protein Folding and Oxidative Stress Pathways in the Drosophila Heart", PLOS GENETICS, vol. 9, no. 12, 19 December 2013 (2013-12-19), pages e1004024, XP055308997, DOI: 10.1371/journal.pgen.1004024 *
HIRANO KOJI ET AL: "The Signification Of Lactoferrin In Secondary Corneal Amyloidosis", 1 April 2011 (2011-04-01), XP055308794, Retrieved from the Internet <URL:http://iovs.arvojournals.org/article.aspx?articleid=2350910> [retrieved on 20161007] *
J. GUAN ET AL: "Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity", EMBO MOLECULAR MEDICINE, vol. 6, no. 11, 1 November 2014 (2014-11-01), Weinheim, pages 1493 - 1507, XP055308912, ISSN: 1757-4676, DOI: 10.15252/emmm.201404190 *

Also Published As

Publication number Publication date
EP3417295A1 (en) 2018-12-26
EP3417295B1 (en) 2020-01-01
WO2017140872A1 (en) 2017-08-24

Similar Documents

Publication Publication Date Title
IL264758B (en) Methods for flexible resource usage
KR102478638B9 (ko) 진단 방법 및 이를 수행하는 기기
PL3660004T3 (pl) Związki i sposoby do ukierunkowanej degradacji receptora androgenowego
EP3472757C0 (en) Computer-based micro-expression analysis
KR20180084817A (ko) 항-siglec-9 항체 및 이의 이용 방법
HUE046756T2 (hu) Benzoxazepin-oxazolidinon vegyületek és azok alkalmazási módszerei
ITUB20169847A1 (it) Metodo per valutare lo stato di salute di un individuo
HUE055263T2 (hu) 11-Szubsztituált 24-hidroxiszterolok NMDA-hoz kapcsolódó állapotok kezelésére
HUE055221T2 (hu) Tetrahidropiranil amino-pirrolopirimidinon és eljárások annak felhasználására
IL257785B (en) Methods of diagnosing and treating conduct disorder
FI20145492A7 (fi) Menetelmä Parkinsonin taudin diagnostiikkaan, hoitoon ja estämiseen
EP3326560A4 (en) ULTRASOUND PROBE
DK3467111T3 (da) LNCRNAS til terapi og diagnose af hjertehypertrofi
ITUA20162317A1 (it) Apparato e metodo per la valutazione dell&#39;assetto di un veicolo.
EP3363497A4 (en) ULTRASOUND STIMULATION HELM
IL256753B (en) Methods and apparatus for simulating interaction of radiation with structures, metrology methods and apparatus, device manufacturing method
EP3712622A4 (en) PROBE HEAD
ITUB20169851A1 (it) Metodo di attenuazione dell’oscillazione di una imbarcazione.
DK4006174T3 (da) Aflang tane til optagelse af et dyreskind og fremgangsmåde til fremstilling deraf
DK3338642T3 (da) Ultralydsdiagnoseanordning og fremgangsmåde til styring af ultralydsdiagnoseanordning
IL264804B (en) Regimens and methods of treating multiple sclerosis using ofatumumab
MA42690A (fr) Micropropagation d&#39;un dattier abada
EP3456262A4 (en) ULTRASONIC PROBE
EP3420912A4 (en) ULTRASONIC PROBE
HUE063820T2 (hu) Módszerek kardiovaszkuláris betegségek kezelésére